The recent emergence of nanomedicine has revolutionized the therapeutic landscape and
necessitated the creation of more sophisticated drug delivery systems. Polymeric …

The acquisition of cancer cell resistance to conventional chemotherapeutics is considered
the major driver of treatment failure and disease recurrence in most solid and hematological …

Resistance to chemotherapy has been a major hurdle that limits therapeutic benefits for
many types of cancer. Here we systematically identify genetic drivers underlying …

Aggressive and recurrent gynecological cancers are associated with worse prognosis and a
lack of effective therapeutic response. Ovarian cancer (OC) patients are often diagnosed in …

There are several interactions within the tumor microenvironment (TME) that affect the
response of cancer cells to therapy. There are also a large number of cells and secretions in …

Simple Summary Breast cancer (BC) is the most frequent malignancy diagnosed in 2020
worldwide. Despite significant advances in BC therapy, its pathogenesis is still not fully …

Cabazitaxel (CZT) loaded chitosan-alginate based (CSA) nanoparticles were developed
with dual targeting functions of both folate receptor and epidermal growth factor receptor …

Paclitaxel, a compound naturally occurring in yew, is a commonly used drug for the
treatment of different types of cancer. Unfortunately, frequent cancer cell resistance …

Biologically active taxanes, present in small-to medium-sized evergreen conifers of various
Taxus species, are widely used for their antioxidant, antimicrobial and anti-inflammatory …

Natural products have proven to be promising anti-cancer agents due to their diverse
chemical structures and bioactivity. This review examines their central role in cancer …